Observational study on acute intoxications in children

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the epidemiology of acute intoxications in children, focusing on the social and care factors associated with these incidents. It is a multicentre observational cohort study conducted by AMIETOX, involving Poison Control Centres and Paediatric emergency rooms. The goal is to gather data that will inform better diagnostic and therapeutic management strategies for acute intoxications in the future.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Subjects between the ages of 1 month and 16 years who report to the PSPs or contact by telephone the CAVs participating in the study with acute intoxication (defined as contact with a substance that is toxic per se or in such quantities as to cause a harmful effect on the body or administered by a route not intended for that substance)

Exclusion Criteria:

* not acquired informed consent

Where it's running

• Ospedale Santa Maria Annunziata
  Bagno a Ripoli, Firenze, Italy Recruiting
• Ospedale Del Mugello
  Borgo San Lorenzo, Firenze, Italy Recruiting
• Ospedale G B Morgagni
  Forlì, Forlì-Cesena, Italy Recruiting
• Mater Salutis
  Legnago, Verona, Italy Recruiting
• Ospedale Maggiore
  Bologna, Italy Recruiting
• Ospedale Centrale Bolzano
  Bolzano, Italy Recruiting

Study contacts

• Study coordinator: Marco De Luca
• Email: marco.deluca@meyer.it
• Phone: 0555662051

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Autoimmune podocytopathy and anti-nephrin antibodies

  This study tests whether children and adults with nephrotic syndrome have anti-nephrin autoantibodies and whether those antibodies relate to relapses and treatment response.

  Recruiting Meyer Children's Hospital IRCCS · Rochester, Minnesota and 13 other locations · NCT07516964

• Pediatric leishmaniasis in Italy: clinical and treatment patterns

  This project will collect medical information to see how leishmaniasis presents and is treated in children under 18 in Italy.

  Recruiting Meyer Children's Hospital IRCCS · Florence, Tuscany · NCT07504757

• Infliximab level monitoring in children with inflammatory bowel disease

  This project will test whether measuring infliximab levels in saliva and leftover blood during the first infusions helps monitor and personalize treatment for children and teens (ages 3–18) with Crohn's disease or ulcerative colitis.

  Recruiting Meyer Children's Hospital IRCCS · Florence, Italy · NCT07470502

• Camptodactyly–Arthropathy–Coxa Vara–Pericarditis (CACP) syndrome patient registry and genetic review

  This registry collects clinical and genetic information to better understand CACP syndrome in children with confirmed PRG4 mutations.

  Recruiting at 3 sites Meyer Children's Hospital IRCCS · Bari and 9 other locations · NCT07468461

• ECD-Score: tracking disease features and outcomes in Erdheim-Chester disease

  This observational project will collect clinical, molecular, and treatment data from people with Erdheim‑Chester disease to try to create an 'ECD‑Score' that tracks disease activity and outcomes.

  Recruiting Meyer Children's Hospital IRCCS · Bethesda, Maryland and 6 other locations · NCT07454343

• Peripheral IV catheter use in children seen in the emergency room

  This test tries adding skin glue under the transparent dressing to help keep peripheral IVs in place for children (0–18) treated in the emergency room.

  Recruiting Meyer Children's Hospital IRCCS · Florence · NCT07450729

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.